We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 29

Federal judge determines RAND royalty rate for standards-essential patents in Microsoft-Motorola dispute

  • Jones Day
  • -
  • USA
  • -
  • May 10 2013

In a much-anticipated decision, a federal district court has, for the first time, calculated specific RAND-compliant royalty rates for

Antitrust alert: fast-forward for FRAND disputes in Europe

  • Jones Day
  • -
  • European Union, Germany
  • -
  • April 11 2013

The Regional Court of Düsseldorf, Germany, has asked the Court of Justice of the European Union ("CJEU") to clarify a number of questions at the

Standards-essential patents and injunctive relief

  • Jones Day
  • -
  • USA
  • -
  • April 9 2013

In a series of fast-moving and interrelated developments involving courts and competition authorities in many regions and countries, holders of

European Court of Justice restricts scope of biotech patents in Europe: Monsanto loses dispute on soy meal

  • Jones Day
  • -
  • European Union
  • -
  • July 19 2010

The European Court of Justice delivered a judgment on July 6, 2010 that certainly may be seen as a breakthrough decision for European biotechnology patent law

Europe's highest court decides on patent term extensions for fixed-combination medicinal products

  • Jones Day
  • -
  • European Union, United Kingdom
  • -
  • December 21 2011

Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European courtthe Court of Justice of the European Union

New FTC pharma patent litigation report finds increase in "reverse payment" settlements based on expanded definition of "payments"

  • Jones Day
  • -
  • USA
  • -
  • February 6 2013

With the Supreme Court set to address the validity of "reverse payment" settlements of pharmaceutical patent litigation, the FTC released a summary

Pan-European preliminary injunctions in patent infringement proceedings: do we still need a European unified court system?

  • Jones Day
  • -
  • European Union
  • -
  • August 24 2012

The Court of Justice of the European Union ("ECJ"), Europe's highest court in charge of interpreting harmonized laws among the 27 member states, has set the scene for a new option in patent infringement proceedings in Europe

The safe harbor for FDA submissions expands: did the Federal Circuit reverse course?

  • Jones Day
  • -
  • USA
  • -
  • August 29 2012

Section 271(e)(1) of the patent code, known as the "safe harbor" provision, immunizes from infringement suits various acts that are undertaken in order to submit information to the Food and Drug Administration ("FDA"

Methods of treatment in Europe: patent claims covering second or further medical uses and dosage regimens

  • Jones Day
  • -
  • European Union
  • -
  • November 18 2010

The decision G 208 of February 19, 2010 (published October 28, 2010) of the Enlarged Board of Appeal (EBA) of the European Patent Office confirms that a substance or composition known as a medicament for treating a certain illness can be patented for use in a different treatment by therapy of the same disease

Europe's landmark decision on stem cell patents, or: the strict European view on life

  • Jones Day
  • -
  • European Union
  • -
  • October 31 2011

In a landmark decision on October 18, 2011, the highest court of the European Unionthe Court of Justicedecided on the patentability of stem-cell-related inventions (case number C-3410

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy